News & Publications

Keep up with our progress

Updates on the latest news, research and collaborations emerging from IBRI.

Newsroom

Press Release 11/17/2025 Indiana Biosciences Research Institute Announces Research Partnership with Eli Lilly and Company Read more Press Release 10/29/2025 Indiana Biosciences Research Institute Keeps MBX Biosciences Growing in Indiana Read more Press Release 10/14/2025 Indiana Biosciences Research Institute Welcomes Dr. Ari Landon as Chief Scientific Business Development Officer Read more News Article 04/05/2024 IU Indianapolis eager to achieve top-tier research status Read more News Article 03/15/2024 Pervasive AI Read more News Article 03/15/2024 Moving AI from the imagination to the real world Read more

Annual Reports

2022 Annual Report Read more 2021 Annual Report Read more 2020 Annual Report Read more 2019 Annual Report Read more 2018 Annual Report Read more 2017 Annual Report Read more 2016 Annual Report Read more

Publications & Presentations

02/01/2024 Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2 Read more 01/11/2024 RIPK3 promotes islet amyloid-induced ß-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes Read more 01/03/2024 Discovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric P13Ka inhibitor that decouples antitumor activity from hyperinsulinemia Read more 10/05/2023 Which small molecule? Selecting chemical probes for use in cancer research and target validation Read more 07/05/2023 Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes Read more 11/22/2022 Therapeutic strategies targeting pancreatic islet beta-cell proliferation, regeneration and replacement Read more

Keep me updated

Sign up for our newsletter to stay updated on IBRI’s progress.

"*" indicates required fields

Name
Explore our pipeline